Aarti Drugs Ltd
Aarti Drugs Ltd Company History
Aarti Drugs is primarily involved in manufacturing and marketing of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals.
2004
Aarti Drugs Ltd. has informed that the Company has changed its Registrar and Share Transfer Agent and Depository interface for Handling Depository related operations by appointing M/s Sharepro Services in place of M/s R & D Consultants Ltd w.e.f. January 16, 2004 subject to completion of necessary formalities as maybe prescribed in this regard. The address and telephone number of M/s Sharepro Services for all investors related services are as under: 1. M/s Sharepro Services, Unit : Aarti Drugs Ltd; 912, Raheja Centre, Free Press Journal Road, Nariman Point, Mumbai 400 021, Tel nos : 22881569, 22884527. 2. M/s Sharepro Services, Unit : Aarti Drugs Ltd; 912, Satam Estate, 3rd Floor, Above Bank of Baroda, Chakla, Andheri (East), Mumbai 400 099, Tel nos : 28215168, 28319828; Fax nos : 28375646.
Aarti bags European certification for three drugs
Delist from Ahmedabad Stock Exchange (ASE) with effect from October 15, 2004.
2004
2006
Aarti Drugs enters into JV with API Manufacturing Chinese Company
Aarti Drugs Ltd. has informed that Mr. Prakash Khedekar, Company Secretary & Compliance Officer of the Company has resigned from the position of Company Secretary & Compliance Officer with effect from October 31, 2006. Further, Mrs. Mona Patel, possessing requisite qualifications, has been appointed as Company Secretary & Compliance Officer of the Company with effect from November 01, 2006.
2006
2009
Aarti Drugs Ltd has has appointed Shri Krishnacharya Govindacharya Akamanchi & Prof. Sudhir Prakash B. Sawant as Independent Directors of the Company.
2009
2010
Aarti Drugs has recommended dividend of Rs. 5/- (50%) per share
2010
2011
Mr. Sunny D. Pagare, has been appointed as Company Secretary & Compliance Officer of the Company
Aarti Drugs has recommended Final Dividend of Rs. 2.5 /-per share (25%)
2011
2012
Mr. Adhish P. Patil, has been appointed as Chief Financial Officer of the Company
Aarti Drugs has declared Final dividend Rs. 3.00 (30%) per share
2012
2013
Aarti Drugs has recommended a Final Dividend of Rs. 4/- per share on Equity Shares of Rs. 10/- each.
2013
2014
Aarti Drugs has commenced the new R&D center at MIDC Tarapur.
Aarti Drugs has recommended a Final dividend @ Rs. 5.50 ps. (55%) per share.
2014
2015
Aarti Drugs Ltd has will participate at 'Centrum Pharma Day' Investor Conference
The Company has allotted the Bonus Shares to its shareholders in the Ratio of 1:1.
2015
2020
The Company has issued Bonus Shares in the Ratio of 3:1.
2020
